Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy

Archives of General Psychiatry

Volumn 59, Issue 5, 2002, Pages 425-433

  Furmark, Tomas ^a   Tillfors, Maria ^a   Marteinsdottir, Ina ^b   Fischer, Håkan ^b,c   Pissiota, Anna ^a   Långström, Bengt ^b   Fredrikson, Mats ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; ATTENUATION; BEHAVIOR THERAPY; BRAIN BLOOD FLOW; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PSYCHOPHYSIOLOGY; SELF REPORT; SOCIAL PHOBIA;

EID: 0036249434     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.5.425     Document Type: Article

References (53)

1. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
2. The economic burden of anxiety disorders in the 1990s
3. SSRIs and SMRIs: Broad spectrum of efficacy beyond major depression
4. Emotion: Clues from the brain
5. Anti-anxiety action of diazepam after intra-amygdaloid application in the rat
6. Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test
7. Functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders
8. The neuropsychology of anxiety: Reprise
9. Social phobia: The most common anxiety disorder
10. Social phobia in the general population: Prevalence and sociodemographic profile
11. Selective serotonin reuptake inhibitors in the treatment of social phobia: The emerging gold standard
12. Treatment of social phobia in cognitive behavioral groups
13. Meta-analysis of cognitive-behavioral treatments for social phobia
14. Social phobia and social anxiety
15. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety
16. Axis V-global assessment of functioning: Evaluation of a self-report version
17. A preliminary evaluation of the Scanditronix PC2048-15B brain scanner
18. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections
19. Tests for distributed, nonfocal brain activations
20. How to estimate global activity independent of changes in local activity
21. A computerized brain atlas: Construction, anatomical content, and some applications
22. CBA: An atlas-based software tool used to facilitate the interpretation of neuroimaging data
23. Implementation and validation of a fully autonomic system for intra- and interindividual registration of PET brain scans
24. A rapid and accurate method to realign PET scans utilizing image edge information
25. Accurate attenuation correction despite movement during PET imaging
26. Statistical parametric maps in functional imaging: A general linear approach
27. Statistical limitations in functional neuroimaging, I: Non-inferential methods and statistical models
28. Comparing functional (PET) images: The assessment of significant change
29. Assessing the significance of focal activations using their spatial extent
30. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia
31. fMRI reveals amygdala activation to human faces in social phobics
32. The application of positron emission tomography to the study of normal and pathologic emotions
33. Brain representation of habituation to repeated complex visual stimulation studied with PET
34. Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli
35. The neuroanatomy of 5-HT dysregulation and panic disorder
36. Neuroanatomical hypothesis of panic disorder, revised
37. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: A PET study
38. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response
39. Neuroimaging studies of mood disorders
40. Functional characteristics of the midbrain periaqueductal gray
41. Cognitive and emotional influences in anterior cingulate cortex
42. Neural structures associated with recognition of facial expressions of basic emotions
43. Brain regions involved in recognizing facial emotion or identity: An oxygen-15 PET study
44. Functional brain imaging and pharmacotherapy in social phobia: Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram
45. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder
46. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder
47. Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers